Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bone Biologics CorpBBLG · Entity 8560 | Director | January 02, 2020 | January 17, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bone Biologics Corp
Report date January 02, 2020 · Filed January 17, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Hankey Capital, LLC | 28,122,518 |
Reported balance
After 2020-01-02 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2020-01-02 · Purchase · Acquired 195,000 · Balance 28,122,518 F1: Consists of shares transferred from H&H Funding LLC to Hankey Capital LLC ("Hankey Capital"). Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Bret Hankey Trust (the "Bret Trust") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the "RB Trust") owns a 0.94% interest and the Hankey Children's Trust (the "Children's Trust") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. F2: Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of shares transferred from H&H Funding LLC to Hankey Capital LLC ("Hankey Capital"). Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Bret Hankey Trust (the "Bret Trust") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the "RB Trust") owns a 0.94% interest and the Hankey Children's Trust (the "Children's Trust") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest.
F2: Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2020 Filed Jan 17, 2020 22:24 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 195,000 | $1.00 | $195,000.00 |
DisclosureSEC source: 0001493152-20-000776 · ownership.xml · nonDerivative · entry 1 Hankey Bret · CIK 0001747562 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 28,122,518 F1 · shares: Consists of shares transferred from H&H Funding LLC to Hankey Capital LLC ("Hankey Capital"). Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Bret Hankey Trust (the "Bret Trust") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the "RB Trust") owns a 0.94% interest and the Hankey Children's Trust (the "Children's Trust") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. F2 · balance_after: Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 17:47 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 553,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-011867 · ownership.xml · nonDerivative · entry 1 Hankey Bret · CIK 0001747562 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 27,829,860 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. F2 · shares: Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Bret Hankey Trust (the "Bret Trust") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the "RB Trust") owns a 0.94% interest and the Hankey Children's Trust (the "Children's Trust") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. F3 · balance_after: Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 17:55 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 85,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-010724 · ownership.xml · nonDerivative · entry 1 Hankey Bret · CIK 0001747562 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · BY HANKEY CAPITAL, LLC Disclosed balance after: Not disclosed F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. F2 · shares: Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Bret Hankey Trust (the "Bret Trust") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the "RB Trust") owns a 0.94% interest and the Hankey Children's Trust (the "Children's Trust") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. F3 · valueOwnedAfter: Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 19:37 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 1,063,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-009559 · ownership.xml · nonDerivative · entry 1 Hankey Bret · CIK 0001747562 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 27,191,563 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. F2 · shares: Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Bret Hankey Trust (the "Bret Trust") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the "RB Trust") owns a 0.94% interest and the Hankey Children's Trust (the "Children's Trust") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. F3 · balance_after: Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. Read SEC document |
| May 07, 2019 Filed May 24, 2019 18:05 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 1,063,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-008226 · ownership.xml · nonDerivative · entry 1 Hankey Bret · CIK 0001747562 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 26,127,733 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. F2 · shares: Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Bret Hankey Trust (the "Bret Trust") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the "RB Trust") owns a 0.94% interest and the Hankey Children's Trust (the "Children's Trust") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. F3 · balance_after: Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 19:37 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 1,489,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-003934 · ownership.xml · nonDerivative · entry 3 Hankey Bret · CIK 0001747562 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · BY HANKEY CAPITAL, LLC Disclosed balance after: 25,063,903 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. F2 · shares: Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Bret Hankey Trust (the "Bret Trust") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the "RB Trust") owns a 0.94% interest and the Hankey Children's Trust (the "Children's Trust") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. F3 · balance_after: Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. Read SEC document |
| December 17, 2018 Filed Mar 26, 2019 19:37 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 18,009,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-003934 · ownership.xml · nonDerivative · entry 2 Hankey Bret · CIK 0001747562 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · BY HANKEY CAPITAL, LLC Disclosed balance after: 23,013,754 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. F2 · shares: Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Bret Hankey Trust (the "Bret Trust") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the "RB Trust") owns a 0.94% interest and the Hankey Children's Trust (the "Children's Trust") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.